Global Cardiopulmonary Autotransfusion System Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Cardiopulmonary Autotransfusion System market size was valued at US$ 584 million in 2024 and is forecast to a readjusted size of USD 685 million by 2031 with a CAGR of 2.3% during review period.
Cardiopulmonary Autotransfusion System is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures.
Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood. There are two main kinds of Autotransfusion: Blood can be autologous 'pre-donated' (termed so despite 'donation' not typically referring to giving to one's self) before a surgery, or alternatively, it can be collected during and after the surgery using an intraoperative blood salvage device. The latter form of Autotransfusion is utilized in surgeries where there is expected a large volume blood loss.
The major players in global Cardiopulmonary Autotransfusion System market include Haemonetics, Medtronic, LivaNova, etc. The top 3 players occupy about 70% shares of the global market. North America and Europe are main markets, they occupy about 80% of the global market. Washed ATS is the main type, with a share about 90%. Heart Surgery is the main application, which holds a share about 35%.
This report is a detailed and comprehensive analysis for global Cardiopulmonary Autotransfusion System market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Cardiopulmonary Autotransfusion System market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Cardiopulmonary Autotransfusion System market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Cardiopulmonary Autotransfusion System market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Cardiopulmonary Autotransfusion System market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cardiopulmonary Autotransfusion System
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cardiopulmonary Autotransfusion System market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Haemonetics, Medtronic, LivaNova, Fresenius Kabi, Terumo, Wandong Health Sources, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Cardiopulmonary Autotransfusion System market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cardiopulmonary Autotransfusion System product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cardiopulmonary Autotransfusion System, with price, sales quantity, revenue, and global market share of Cardiopulmonary Autotransfusion System from 2020 to 2025.
Chapter 3, the Cardiopulmonary Autotransfusion System competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cardiopulmonary Autotransfusion System breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Cardiopulmonary Autotransfusion System market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cardiopulmonary Autotransfusion System.
Chapter 14 and 15, to describe Cardiopulmonary Autotransfusion System sales channel, distributors, customers, research findings and conclusion.
Cardiopulmonary Autotransfusion System is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures.
Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood. There are two main kinds of Autotransfusion: Blood can be autologous 'pre-donated' (termed so despite 'donation' not typically referring to giving to one's self) before a surgery, or alternatively, it can be collected during and after the surgery using an intraoperative blood salvage device. The latter form of Autotransfusion is utilized in surgeries where there is expected a large volume blood loss.
The major players in global Cardiopulmonary Autotransfusion System market include Haemonetics, Medtronic, LivaNova, etc. The top 3 players occupy about 70% shares of the global market. North America and Europe are main markets, they occupy about 80% of the global market. Washed ATS is the main type, with a share about 90%. Heart Surgery is the main application, which holds a share about 35%.
This report is a detailed and comprehensive analysis for global Cardiopulmonary Autotransfusion System market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Cardiopulmonary Autotransfusion System market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Cardiopulmonary Autotransfusion System market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Cardiopulmonary Autotransfusion System market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Cardiopulmonary Autotransfusion System market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cardiopulmonary Autotransfusion System
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cardiopulmonary Autotransfusion System market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Haemonetics, Medtronic, LivaNova, Fresenius Kabi, Terumo, Wandong Health Sources, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Cardiopulmonary Autotransfusion System market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Unwashed ATS
- Washed ATS
- Heart Surgery
- Great Organ Transplant Surgery
- Other Surgery
- Haemonetics
- Medtronic
- LivaNova
- Fresenius Kabi
- Terumo
- Wandong Health Sources
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cardiopulmonary Autotransfusion System product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cardiopulmonary Autotransfusion System, with price, sales quantity, revenue, and global market share of Cardiopulmonary Autotransfusion System from 2020 to 2025.
Chapter 3, the Cardiopulmonary Autotransfusion System competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cardiopulmonary Autotransfusion System breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Cardiopulmonary Autotransfusion System market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cardiopulmonary Autotransfusion System.
Chapter 14 and 15, to describe Cardiopulmonary Autotransfusion System sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Cardiopulmonary Autotransfusion System Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Unwashed ATS
1.3.3 Washed ATS
1.4 Market Analysis by Application
1.4.1 Overview: Global Cardiopulmonary Autotransfusion System Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Heart Surgery
1.4.3 Great Organ Transplant Surgery
1.4.4 Other Surgery
1.5 Global Cardiopulmonary Autotransfusion System Market Size & Forecast
1.5.1 Global Cardiopulmonary Autotransfusion System Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Cardiopulmonary Autotransfusion System Sales Quantity (2020-2031)
1.5.3 Global Cardiopulmonary Autotransfusion System Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Haemonetics
2.1.1 Haemonetics Details
2.1.2 Haemonetics Major Business
2.1.3 Haemonetics Cardiopulmonary Autotransfusion System Product and Services
2.1.4 Haemonetics Cardiopulmonary Autotransfusion System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Haemonetics Recent Developments/Updates
2.2 Medtronic
2.2.1 Medtronic Details
2.2.2 Medtronic Major Business
2.2.3 Medtronic Cardiopulmonary Autotransfusion System Product and Services
2.2.4 Medtronic Cardiopulmonary Autotransfusion System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Medtronic Recent Developments/Updates
2.3 LivaNova
2.3.1 LivaNova Details
2.3.2 LivaNova Major Business
2.3.3 LivaNova Cardiopulmonary Autotransfusion System Product and Services
2.3.4 LivaNova Cardiopulmonary Autotransfusion System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 LivaNova Recent Developments/Updates
2.4 Fresenius Kabi
2.4.1 Fresenius Kabi Details
2.4.2 Fresenius Kabi Major Business
2.4.3 Fresenius Kabi Cardiopulmonary Autotransfusion System Product and Services
2.4.4 Fresenius Kabi Cardiopulmonary Autotransfusion System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Fresenius Kabi Recent Developments/Updates
2.5 Terumo
2.5.1 Terumo Details
2.5.2 Terumo Major Business
2.5.3 Terumo Cardiopulmonary Autotransfusion System Product and Services
2.5.4 Terumo Cardiopulmonary Autotransfusion System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Terumo Recent Developments/Updates
2.6 Wandong Health Sources
2.6.1 Wandong Health Sources Details
2.6.2 Wandong Health Sources Major Business
2.6.3 Wandong Health Sources Cardiopulmonary Autotransfusion System Product and Services
2.6.4 Wandong Health Sources Cardiopulmonary Autotransfusion System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Wandong Health Sources Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: CARDIOPULMONARY AUTOTRANSFUSION SYSTEM BY MANUFACTURER
3.1 Global Cardiopulmonary Autotransfusion System Sales Quantity by Manufacturer (2020-2025)
3.2 Global Cardiopulmonary Autotransfusion System Revenue by Manufacturer (2020-2025)
3.3 Global Cardiopulmonary Autotransfusion System Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Cardiopulmonary Autotransfusion System by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Cardiopulmonary Autotransfusion System Manufacturer Market Share in 2024
3.4.3 Top 6 Cardiopulmonary Autotransfusion System Manufacturer Market Share in 2024
3.5 Cardiopulmonary Autotransfusion System Market: Overall Company Footprint Analysis
3.5.1 Cardiopulmonary Autotransfusion System Market: Region Footprint
3.5.2 Cardiopulmonary Autotransfusion System Market: Company Product Type Footprint
3.5.3 Cardiopulmonary Autotransfusion System Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Cardiopulmonary Autotransfusion System Market Size by Region
4.1.1 Global Cardiopulmonary Autotransfusion System Sales Quantity by Region (2020-2031)
4.1.2 Global Cardiopulmonary Autotransfusion System Consumption Value by Region (2020-2031)
4.1.3 Global Cardiopulmonary Autotransfusion System Average Price by Region (2020-2031)
4.2 North America Cardiopulmonary Autotransfusion System Consumption Value (2020-2031)
4.3 Europe Cardiopulmonary Autotransfusion System Consumption Value (2020-2031)
4.4 Asia-Pacific Cardiopulmonary Autotransfusion System Consumption Value (2020-2031)
4.5 South America Cardiopulmonary Autotransfusion System Consumption Value (2020-2031)
4.6 Middle East & Africa Cardiopulmonary Autotransfusion System Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Cardiopulmonary Autotransfusion System Sales Quantity by Type (2020-2031)
5.2 Global Cardiopulmonary Autotransfusion System Consumption Value by Type (2020-2031)
5.3 Global Cardiopulmonary Autotransfusion System Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Cardiopulmonary Autotransfusion System Sales Quantity by Application (2020-2031)
6.2 Global Cardiopulmonary Autotransfusion System Consumption Value by Application (2020-2031)
6.3 Global Cardiopulmonary Autotransfusion System Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Cardiopulmonary Autotransfusion System Sales Quantity by Type (2020-2031)
7.2 North America Cardiopulmonary Autotransfusion System Sales Quantity by Application (2020-2031)
7.3 North America Cardiopulmonary Autotransfusion System Market Size by Country
7.3.1 North America Cardiopulmonary Autotransfusion System Sales Quantity by Country (2020-2031)
7.3.2 North America Cardiopulmonary Autotransfusion System Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Cardiopulmonary Autotransfusion System Sales Quantity by Type (2020-2031)
8.2 Europe Cardiopulmonary Autotransfusion System Sales Quantity by Application (2020-2031)
8.3 Europe Cardiopulmonary Autotransfusion System Market Size by Country
8.3.1 Europe Cardiopulmonary Autotransfusion System Sales Quantity by Country (2020-2031)
8.3.2 Europe Cardiopulmonary Autotransfusion System Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Cardiopulmonary Autotransfusion System Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Cardiopulmonary Autotransfusion System Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Cardiopulmonary Autotransfusion System Market Size by Region
9.3.1 Asia-Pacific Cardiopulmonary Autotransfusion System Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Cardiopulmonary Autotransfusion System Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Cardiopulmonary Autotransfusion System Sales Quantity by Type (2020-2031)
10.2 South America Cardiopulmonary Autotransfusion System Sales Quantity by Application (2020-2031)
10.3 South America Cardiopulmonary Autotransfusion System Market Size by Country
10.3.1 South America Cardiopulmonary Autotransfusion System Sales Quantity by Country (2020-2031)
10.3.2 South America Cardiopulmonary Autotransfusion System Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Cardiopulmonary Autotransfusion System Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Cardiopulmonary Autotransfusion System Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Cardiopulmonary Autotransfusion System Market Size by Country
11.3.1 Middle East & Africa Cardiopulmonary Autotransfusion System Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Cardiopulmonary Autotransfusion System Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Cardiopulmonary Autotransfusion System Market Drivers
12.2 Cardiopulmonary Autotransfusion System Market Restraints
12.3 Cardiopulmonary Autotransfusion System Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Cardiopulmonary Autotransfusion System and Key Manufacturers
13.2 Manufacturing Costs Percentage of Cardiopulmonary Autotransfusion System
13.3 Cardiopulmonary Autotransfusion System Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Cardiopulmonary Autotransfusion System Typical Distributors
14.3 Cardiopulmonary Autotransfusion System Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OFTABLES
Table 1. Global Cardiopulmonary Autotransfusion System Consumption Value byType, (USD Million), 2020 & 2024 & 2031
Table 2. Global Cardiopulmonary Autotransfusion System Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Haemonetics Basic Information, Manufacturing Base and Competitors
Table 4. Haemonetics Major Business
Table 5. Haemonetics Cardiopulmonary Autotransfusion System Product and Services
Table 6. Haemonetics Cardiopulmonary Autotransfusion System Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Haemonetics Recent Developments/Updates
Table 8. Medtronic Basic Information, Manufacturing Base and Competitors
Table 9. Medtronic Major Business
Table 10. Medtronic Cardiopulmonary Autotransfusion System Product and Services
Table 11. Medtronic Cardiopulmonary Autotransfusion System Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Medtronic Recent Developments/Updates
Table 13. LivaNova Basic Information, Manufacturing Base and Competitors
Table 14. LivaNova Major Business
Table 15. LivaNova Cardiopulmonary Autotransfusion System Product and Services
Table 16. LivaNova Cardiopulmonary Autotransfusion System Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. LivaNova Recent Developments/Updates
Table 18.Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 19.Fresenius Kabi Major Business
Table 20.Fresenius Kabi Cardiopulmonary Autotransfusion System Product and Services
Table 21.Fresenius Kabi Cardiopulmonary Autotransfusion System Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22.Fresenius Kabi Recent Developments/Updates
Table 23.Terumo Basic Information, Manufacturing Base and Competitors
Table 24.Terumo Major Business
Table 25.Terumo Cardiopulmonary Autotransfusion System Product and Services
Table 26.Terumo Cardiopulmonary Autotransfusion System Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27.Terumo Recent Developments/Updates
Table 28. Wandong Health Sources Basic Information, Manufacturing Base and Competitors
Table 29. Wandong Health Sources Major Business
Table 30. Wandong Health Sources Cardiopulmonary Autotransfusion System Product and Services
Table 31. Wandong Health Sources Cardiopulmonary Autotransfusion System Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. Wandong Health Sources Recent Developments/Updates
Table 33. Global Cardiopulmonary Autotransfusion System Sales Quantity by Manufacturer (2020-2025) & (K Units)
Table 34. Global Cardiopulmonary Autotransfusion System Revenue by Manufacturer (2020-2025) & (USD Million)
Table 35. Global Cardiopulmonary Autotransfusion System Average Price by Manufacturer (2020-2025) & (USD/Unit)
Table 36. Market Position of Manufacturers in Cardiopulmonary Autotransfusion System, (Tier 1,Tier 2, andTier 3), Based on Revenue in 2024
Table 37. Head Office and Cardiopulmonary Autotransfusion System Production Site of Key Manufacturer
Table 38. Cardiopulmonary Autotransfusion System Market: Company ProductTypeFootprint
Table 39. Cardiopulmonary Autotransfusion System Market: Company Product ApplicationFootprint
Table 40. Cardiopulmonary Autotransfusion System New Market Entrants and Barriers to Market Entry
Table 41. Cardiopulmonary Autotransfusion System Mergers, Acquisition, Agreements, and Collaborations
Table 42. Global Cardiopulmonary Autotransfusion System Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 43. Global Cardiopulmonary Autotransfusion System Sales Quantity by Region (2020-2025) & (K Units)
Table 44. Global Cardiopulmonary Autotransfusion System Sales Quantity by Region (2026-2031) & (K Units)
Table 45. Global Cardiopulmonary Autotransfusion System Consumption Value by Region (2020-2025) & (USD Million)
Table 46. Global Cardiopulmonary Autotransfusion System Consumption Value by Region (2026-2031) & (USD Million)
Table 47. Global Cardiopulmonary Autotransfusion System Average Price by Region (2020-2025) & (USD/Unit)
Table 48. Global Cardiopulmonary Autotransfusion System Average Price by Region (2026-2031) & (USD/Unit)
Table 49. Global Cardiopulmonary Autotransfusion System Sales Quantity byType (2020-2025) & (K Units)
Table 50. Global Cardiopulmonary Autotransfusion System Sales Quantity byType (2026-2031) & (K Units)
Table 51. Global Cardiopulmonary Autotransfusion System Consumption Value byType (2020-2025) & (USD Million)
Table 52. Global Cardiopulmonary Autotransfusion System Consumption Value byType (2026-2031) & (USD Million)
Table 53. Global Cardiopulmonary Autotransfusion System Average Price byType (2020-2025) & (USD/Unit)
Table 54. Global Cardiopulmonary Autotransfusion System Average Price byType (2026-2031) & (USD/Unit)
Table 55. Global Cardiopulmonary Autotransfusion System Sales Quantity by Application (2020-2025) & (K Units)
Table 56. Global Cardiopulmonary Autotransfusion System Sales Quantity by Application (2026-2031) & (K Units)
Table 57. Global Cardiopulmonary Autotransfusion System Consumption Value by Application (2020-2025) & (USD Million)
Table 58. Global Cardiopulmonary Autotransfusion System Consumption Value by Application (2026-2031) & (USD Million)
Table 59. Global Cardiopulmonary Autotransfusion System Average Price by Application (2020-2025) & (USD/Unit)
Table 60. Global Cardiopulmonary Autotransfusion System Average Price by Application (2026-2031) & (USD/Unit)
Table 61. North America Cardiopulmonary Autotransfusion System Sales Quantity byType (2020-2025) & (K Units)
Table 62. North America Cardiopulmonary Autotransfusion System Sales Quantity byType (2026-2031) & (K Units)
Table 63. North America Cardiopulmonary Autotransfusion System Sales Quantity by Application (2020-2025) & (K Units)
Table 64. North America Cardiopulmonary Autotransfusion System Sales Quantity by Application (2026-2031) & (K Units)
Table 65. North America Cardiopulmonary Autotransfusion System Sales Quantity by Country (2020-2025) & (K Units)
Table 66. North America Cardiopulmonary Autotransfusion System Sales Quantity by Country (2026-2031) & (K Units)
Table 67. North America Cardiopulmonary Autotransfusion System Consumption Value by Country (2020-2025) & (USD Million)
Table 68. North America Cardiopulmonary Autotransfusion System Consumption Value by Country (2026-2031) & (USD Million)
Table 69. Europe Cardiopulmonary Autotransfusion System Sales Quantity byType (2020-2025) & (K Units)
Table 70. Europe Cardiopulmonary Autotransfusion System Sales Quantity byType (2026-2031) & (K Units)
Table 71. Europe Cardiopulmonary Autotransfusion System Sales Quantity by Application (2020-2025) & (K Units)
Table 72. Europe Cardiopulmonary Autotransfusion System Sales Quantity by Application (2026-2031) & (K Units)
Table 73. Europe Cardiopulmonary Autotransfusion System Sales Quantity by Country (2020-2025) & (K Units)
Table 74. Europe Cardiopulmonary Autotransfusion System Sales Quantity by Country (2026-2031) & (K Units)
Table 75. Europe Cardiopulmonary Autotransfusion System Consumption Value by Country (2020-2025) & (USD Million)
Table 76. Europe Cardiopulmonary Autotransfusion System Consumption Value by Country (2026-2031) & (USD Million)
Table 77. Asia-Pacific Cardiopulmonary Autotransfusion System Sales Quantity byType (2020-2025) & (K Units)
Table 78. Asia-Pacific Cardiopulmonary Autotransfusion System Sales Quantity byType (2026-2031) & (K Units)
Table 79. Asia-Pacific Cardiopulmonary Autotransfusion System Sales Quantity by Application (2020-2025) & (K Units)
Table 80. Asia-Pacific Cardiopulmonary Autotransfusion System Sales Quantity by Application (2026-2031) & (K Units)
Table 81. Asia-Pacific Cardiopulmonary Autotransfusion System Sales Quantity by Region (2020-2025) & (K Units)
Table 82. Asia-Pacific Cardiopulmonary Autotransfusion System Sales Quantity by Region (2026-2031) & (K Units)
Table 83. Asia-Pacific Cardiopulmonary Autotransfusion System Consumption Value by Region (2020-2025) & (USD Million)
Table 84. Asia-Pacific Cardiopulmonary Autotransfusion System Consumption Value by Region (2026-2031) & (USD Million)
Table 85. South America Cardiopulmonary Autotransfusion System Sales Quantity byType (2020-2025) & (K Units)
Table 86. South America Cardiopulmonary Autotransfusion System Sales Quantity byType (2026-2031) & (K Units)
Table 87. South America Cardiopulmonary Autotransfusion System Sales Quantity by Application (2020-2025) & (K Units)
Table 88. South America Cardiopulmonary Autotransfusion System Sales Quantity by Application (2026-2031) & (K Units)
Table 89. South America Cardiopulmonary Autotransfusion System Sales Quantity by Country (2020-2025) & (K Units)
Table 90. South America Cardiopulmonary Autotransfusion System Sales Quantity by Country (2026-2031) & (K Units)
Table 91. South America Cardiopulmonary Autotransfusion System Consumption Value by Country (2020-2025) & (USD Million)
Table 92. South America Cardiopulmonary Autotransfusion System Consumption Value by Country (2026-2031) & (USD Million)
Table 93. Middle East & Africa Cardiopulmonary Autotransfusion System Sales Quantity byType (2020-2025) & (K Units)
Table 94. Middle East & Africa Cardiopulmonary Autotransfusion System Sales Quantity byType (2026-2031) & (K Units)
Table 95. Middle East & Africa Cardiopulmonary Autotransfusion System Sales Quantity by Application (2020-2025) & (K Units)
Table 96. Middle East & Africa Cardiopulmonary Autotransfusion System Sales Quantity by Application (2026-2031) & (K Units)
Table 97. Middle East & Africa Cardiopulmonary Autotransfusion System Sales Quantity by Country (2020-2025) & (K Units)
Table 98. Middle East & Africa Cardiopulmonary Autotransfusion System Sales Quantity by Country (2026-2031) & (K Units)
Table 99. Middle East & Africa Cardiopulmonary Autotransfusion System Consumption Value by Country (2020-2025) & (USD Million)
Table 100. Middle East & Africa Cardiopulmonary Autotransfusion System Consumption Value by Country (2026-2031) & (USD Million)
Table 101. Cardiopulmonary Autotransfusion System Raw Material
Table 102. Key Manufacturers of Cardiopulmonary Autotransfusion System Raw Materials
Table 103. Cardiopulmonary Autotransfusion SystemTypical Distributors
Table 104. Cardiopulmonary Autotransfusion SystemTypical Customers
LIST OFFIGURES
Figure 1. Cardiopulmonary Autotransfusion System Picture
Figure 2. Global Cardiopulmonary Autotransfusion System Revenue byType, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Cardiopulmonary Autotransfusion System Revenue Market Share byType in 2024
Figure 4. Unwashed ATS Examples
Figure 5. Washed ATS Examples
Figure 6. Global Cardiopulmonary Autotransfusion System Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. Global Cardiopulmonary Autotransfusion System Revenue Market Share by Application in 2024
Figure 8. Heart Surgery Examples
Figure 9. Great OrganTransplant Surgery Examples
Figure 10. Other Surgery Examples
Figure 11. Global Cardiopulmonary Autotransfusion System Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 12. Global Cardiopulmonary Autotransfusion System Consumption Value andForecast (2020-2031) & (USD Million)
Figure 13. Global Cardiopulmonary Autotransfusion System Sales Quantity (2020-2031) & (K Units)
Figure 14. Global Cardiopulmonary Autotransfusion System Price (2020-2031) & (USD/Unit)
Figure 15. Global Cardiopulmonary Autotransfusion System Sales Quantity Market Share by Manufacturer in 2024
Figure 16. Global Cardiopulmonary Autotransfusion System Revenue Market Share by Manufacturer in 2024
Figure 17. Producer Shipments of Cardiopulmonary Autotransfusion System by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 18.Top 3 Cardiopulmonary Autotransfusion System Manufacturer (Revenue) Market Share in 2024
Figure 19.Top 6 Cardiopulmonary Autotransfusion System Manufacturer (Revenue) Market Share in 2024
Figure 20. Global Cardiopulmonary Autotransfusion System Sales Quantity Market Share by Region (2020-2031)
Figure 21. Global Cardiopulmonary Autotransfusion System Consumption Value Market Share by Region (2020-2031)
Figure 22. North America Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 23. Europe Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 24. Asia-Pacific Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 25. South America Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 26. Middle East & Africa Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 27. Global Cardiopulmonary Autotransfusion System Sales Quantity Market Share byType (2020-2031)
Figure 28. Global Cardiopulmonary Autotransfusion System Consumption Value Market Share byType (2020-2031)
Figure 29. Global Cardiopulmonary Autotransfusion System Average Price byType (2020-2031) & (USD/Unit)
Figure 30. Global Cardiopulmonary Autotransfusion System Sales Quantity Market Share by Application (2020-2031)
Figure 31. Global Cardiopulmonary Autotransfusion System Revenue Market Share by Application (2020-2031)
Figure 32. Global Cardiopulmonary Autotransfusion System Average Price by Application (2020-2031) & (USD/Unit)
Figure 33. North America Cardiopulmonary Autotransfusion System Sales Quantity Market Share byType (2020-2031)
Figure 34. North America Cardiopulmonary Autotransfusion System Sales Quantity Market Share by Application (2020-2031)
Figure 35. North America Cardiopulmonary Autotransfusion System Sales Quantity Market Share by Country (2020-2031)
Figure 36. North America Cardiopulmonary Autotransfusion System Consumption Value Market Share by Country (2020-2031)
Figure 37. United States Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 38. Canada Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 39. Mexico Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 40. Europe Cardiopulmonary Autotransfusion System Sales Quantity Market Share byType (2020-2031)
Figure 41. Europe Cardiopulmonary Autotransfusion System Sales Quantity Market Share by Application (2020-2031)
Figure 42. Europe Cardiopulmonary Autotransfusion System Sales Quantity Market Share by Country (2020-2031)
Figure 43. Europe Cardiopulmonary Autotransfusion System Consumption Value Market Share by Country (2020-2031)
Figure 44. Germany Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 45.France Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 46. United Kingdom Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 47. Russia Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 48. Italy Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 49. Asia-Pacific Cardiopulmonary Autotransfusion System Sales Quantity Market Share byType (2020-2031)
Figure 50. Asia-Pacific Cardiopulmonary Autotransfusion System Sales Quantity Market Share by Application (2020-2031)
Figure 51. Asia-Pacific Cardiopulmonary Autotransfusion System Sales Quantity Market Share by Region (2020-2031)
Figure 52. Asia-Pacific Cardiopulmonary Autotransfusion System Consumption Value Market Share by Region (2020-2031)
Figure 53. China Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 54. Japan Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 55. South Korea Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 56. India Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 57. Southeast Asia Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 58. Australia Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 59. South America Cardiopulmonary Autotransfusion System Sales Quantity Market Share byType (2020-2031)
Figure 60. South America Cardiopulmonary Autotransfusion System Sales Quantity Market Share by Application (2020-2031)
Figure 61. South America Cardiopulmonary Autotransfusion System Sales Quantity Market Share by Country (2020-2031)
Figure 62. South America Cardiopulmonary Autotransfusion System Consumption Value Market Share by Country (2020-2031)
Figure 63. Brazil Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 64. Argentina Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 65. Middle East & Africa Cardiopulmonary Autotransfusion System Sales Quantity Market Share byType (2020-2031)
Figure 66. Middle East & Africa Cardiopulmonary Autotransfusion System Sales Quantity Market Share by Application (2020-2031)
Figure 67. Middle East & Africa Cardiopulmonary Autotransfusion System Sales Quantity Market Share by Country (2020-2031)
Figure 68. Middle East & Africa Cardiopulmonary Autotransfusion System Consumption Value Market Share by Country (2020-2031)
Figure 69.Turkey Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 70. Egypt Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 71. Saudi Arabia Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 72. South Africa Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 73. Cardiopulmonary Autotransfusion System Market Drivers
Figure 74. Cardiopulmonary Autotransfusion System Market Restraints
Figure 75. Cardiopulmonary Autotransfusion System MarketTrends
Figure 76. PortersFiveForces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Cardiopulmonary Autotransfusion System in 2024
Figure 78. Manufacturing Process Analysis of Cardiopulmonary Autotransfusion System
Figure 79. Cardiopulmonary Autotransfusion System Industrial Chain
Figure 80. Sales Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Cardiopulmonary Autotransfusion System Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Unwashed ATS
1.3.3 Washed ATS
1.4 Market Analysis by Application
1.4.1 Overview: Global Cardiopulmonary Autotransfusion System Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Heart Surgery
1.4.3 Great Organ Transplant Surgery
1.4.4 Other Surgery
1.5 Global Cardiopulmonary Autotransfusion System Market Size & Forecast
1.5.1 Global Cardiopulmonary Autotransfusion System Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Cardiopulmonary Autotransfusion System Sales Quantity (2020-2031)
1.5.3 Global Cardiopulmonary Autotransfusion System Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Haemonetics
2.1.1 Haemonetics Details
2.1.2 Haemonetics Major Business
2.1.3 Haemonetics Cardiopulmonary Autotransfusion System Product and Services
2.1.4 Haemonetics Cardiopulmonary Autotransfusion System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Haemonetics Recent Developments/Updates
2.2 Medtronic
2.2.1 Medtronic Details
2.2.2 Medtronic Major Business
2.2.3 Medtronic Cardiopulmonary Autotransfusion System Product and Services
2.2.4 Medtronic Cardiopulmonary Autotransfusion System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Medtronic Recent Developments/Updates
2.3 LivaNova
2.3.1 LivaNova Details
2.3.2 LivaNova Major Business
2.3.3 LivaNova Cardiopulmonary Autotransfusion System Product and Services
2.3.4 LivaNova Cardiopulmonary Autotransfusion System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 LivaNova Recent Developments/Updates
2.4 Fresenius Kabi
2.4.1 Fresenius Kabi Details
2.4.2 Fresenius Kabi Major Business
2.4.3 Fresenius Kabi Cardiopulmonary Autotransfusion System Product and Services
2.4.4 Fresenius Kabi Cardiopulmonary Autotransfusion System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Fresenius Kabi Recent Developments/Updates
2.5 Terumo
2.5.1 Terumo Details
2.5.2 Terumo Major Business
2.5.3 Terumo Cardiopulmonary Autotransfusion System Product and Services
2.5.4 Terumo Cardiopulmonary Autotransfusion System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Terumo Recent Developments/Updates
2.6 Wandong Health Sources
2.6.1 Wandong Health Sources Details
2.6.2 Wandong Health Sources Major Business
2.6.3 Wandong Health Sources Cardiopulmonary Autotransfusion System Product and Services
2.6.4 Wandong Health Sources Cardiopulmonary Autotransfusion System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Wandong Health Sources Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: CARDIOPULMONARY AUTOTRANSFUSION SYSTEM BY MANUFACTURER
3.1 Global Cardiopulmonary Autotransfusion System Sales Quantity by Manufacturer (2020-2025)
3.2 Global Cardiopulmonary Autotransfusion System Revenue by Manufacturer (2020-2025)
3.3 Global Cardiopulmonary Autotransfusion System Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Cardiopulmonary Autotransfusion System by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Cardiopulmonary Autotransfusion System Manufacturer Market Share in 2024
3.4.3 Top 6 Cardiopulmonary Autotransfusion System Manufacturer Market Share in 2024
3.5 Cardiopulmonary Autotransfusion System Market: Overall Company Footprint Analysis
3.5.1 Cardiopulmonary Autotransfusion System Market: Region Footprint
3.5.2 Cardiopulmonary Autotransfusion System Market: Company Product Type Footprint
3.5.3 Cardiopulmonary Autotransfusion System Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Cardiopulmonary Autotransfusion System Market Size by Region
4.1.1 Global Cardiopulmonary Autotransfusion System Sales Quantity by Region (2020-2031)
4.1.2 Global Cardiopulmonary Autotransfusion System Consumption Value by Region (2020-2031)
4.1.3 Global Cardiopulmonary Autotransfusion System Average Price by Region (2020-2031)
4.2 North America Cardiopulmonary Autotransfusion System Consumption Value (2020-2031)
4.3 Europe Cardiopulmonary Autotransfusion System Consumption Value (2020-2031)
4.4 Asia-Pacific Cardiopulmonary Autotransfusion System Consumption Value (2020-2031)
4.5 South America Cardiopulmonary Autotransfusion System Consumption Value (2020-2031)
4.6 Middle East & Africa Cardiopulmonary Autotransfusion System Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Cardiopulmonary Autotransfusion System Sales Quantity by Type (2020-2031)
5.2 Global Cardiopulmonary Autotransfusion System Consumption Value by Type (2020-2031)
5.3 Global Cardiopulmonary Autotransfusion System Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Cardiopulmonary Autotransfusion System Sales Quantity by Application (2020-2031)
6.2 Global Cardiopulmonary Autotransfusion System Consumption Value by Application (2020-2031)
6.3 Global Cardiopulmonary Autotransfusion System Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Cardiopulmonary Autotransfusion System Sales Quantity by Type (2020-2031)
7.2 North America Cardiopulmonary Autotransfusion System Sales Quantity by Application (2020-2031)
7.3 North America Cardiopulmonary Autotransfusion System Market Size by Country
7.3.1 North America Cardiopulmonary Autotransfusion System Sales Quantity by Country (2020-2031)
7.3.2 North America Cardiopulmonary Autotransfusion System Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Cardiopulmonary Autotransfusion System Sales Quantity by Type (2020-2031)
8.2 Europe Cardiopulmonary Autotransfusion System Sales Quantity by Application (2020-2031)
8.3 Europe Cardiopulmonary Autotransfusion System Market Size by Country
8.3.1 Europe Cardiopulmonary Autotransfusion System Sales Quantity by Country (2020-2031)
8.3.2 Europe Cardiopulmonary Autotransfusion System Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Cardiopulmonary Autotransfusion System Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Cardiopulmonary Autotransfusion System Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Cardiopulmonary Autotransfusion System Market Size by Region
9.3.1 Asia-Pacific Cardiopulmonary Autotransfusion System Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Cardiopulmonary Autotransfusion System Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Cardiopulmonary Autotransfusion System Sales Quantity by Type (2020-2031)
10.2 South America Cardiopulmonary Autotransfusion System Sales Quantity by Application (2020-2031)
10.3 South America Cardiopulmonary Autotransfusion System Market Size by Country
10.3.1 South America Cardiopulmonary Autotransfusion System Sales Quantity by Country (2020-2031)
10.3.2 South America Cardiopulmonary Autotransfusion System Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Cardiopulmonary Autotransfusion System Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Cardiopulmonary Autotransfusion System Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Cardiopulmonary Autotransfusion System Market Size by Country
11.3.1 Middle East & Africa Cardiopulmonary Autotransfusion System Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Cardiopulmonary Autotransfusion System Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Cardiopulmonary Autotransfusion System Market Drivers
12.2 Cardiopulmonary Autotransfusion System Market Restraints
12.3 Cardiopulmonary Autotransfusion System Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Cardiopulmonary Autotransfusion System and Key Manufacturers
13.2 Manufacturing Costs Percentage of Cardiopulmonary Autotransfusion System
13.3 Cardiopulmonary Autotransfusion System Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Cardiopulmonary Autotransfusion System Typical Distributors
14.3 Cardiopulmonary Autotransfusion System Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OFTABLES
Table 1. Global Cardiopulmonary Autotransfusion System Consumption Value byType, (USD Million), 2020 & 2024 & 2031
Table 2. Global Cardiopulmonary Autotransfusion System Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Haemonetics Basic Information, Manufacturing Base and Competitors
Table 4. Haemonetics Major Business
Table 5. Haemonetics Cardiopulmonary Autotransfusion System Product and Services
Table 6. Haemonetics Cardiopulmonary Autotransfusion System Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Haemonetics Recent Developments/Updates
Table 8. Medtronic Basic Information, Manufacturing Base and Competitors
Table 9. Medtronic Major Business
Table 10. Medtronic Cardiopulmonary Autotransfusion System Product and Services
Table 11. Medtronic Cardiopulmonary Autotransfusion System Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Medtronic Recent Developments/Updates
Table 13. LivaNova Basic Information, Manufacturing Base and Competitors
Table 14. LivaNova Major Business
Table 15. LivaNova Cardiopulmonary Autotransfusion System Product and Services
Table 16. LivaNova Cardiopulmonary Autotransfusion System Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. LivaNova Recent Developments/Updates
Table 18.Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 19.Fresenius Kabi Major Business
Table 20.Fresenius Kabi Cardiopulmonary Autotransfusion System Product and Services
Table 21.Fresenius Kabi Cardiopulmonary Autotransfusion System Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22.Fresenius Kabi Recent Developments/Updates
Table 23.Terumo Basic Information, Manufacturing Base and Competitors
Table 24.Terumo Major Business
Table 25.Terumo Cardiopulmonary Autotransfusion System Product and Services
Table 26.Terumo Cardiopulmonary Autotransfusion System Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27.Terumo Recent Developments/Updates
Table 28. Wandong Health Sources Basic Information, Manufacturing Base and Competitors
Table 29. Wandong Health Sources Major Business
Table 30. Wandong Health Sources Cardiopulmonary Autotransfusion System Product and Services
Table 31. Wandong Health Sources Cardiopulmonary Autotransfusion System Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. Wandong Health Sources Recent Developments/Updates
Table 33. Global Cardiopulmonary Autotransfusion System Sales Quantity by Manufacturer (2020-2025) & (K Units)
Table 34. Global Cardiopulmonary Autotransfusion System Revenue by Manufacturer (2020-2025) & (USD Million)
Table 35. Global Cardiopulmonary Autotransfusion System Average Price by Manufacturer (2020-2025) & (USD/Unit)
Table 36. Market Position of Manufacturers in Cardiopulmonary Autotransfusion System, (Tier 1,Tier 2, andTier 3), Based on Revenue in 2024
Table 37. Head Office and Cardiopulmonary Autotransfusion System Production Site of Key Manufacturer
Table 38. Cardiopulmonary Autotransfusion System Market: Company ProductTypeFootprint
Table 39. Cardiopulmonary Autotransfusion System Market: Company Product ApplicationFootprint
Table 40. Cardiopulmonary Autotransfusion System New Market Entrants and Barriers to Market Entry
Table 41. Cardiopulmonary Autotransfusion System Mergers, Acquisition, Agreements, and Collaborations
Table 42. Global Cardiopulmonary Autotransfusion System Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 43. Global Cardiopulmonary Autotransfusion System Sales Quantity by Region (2020-2025) & (K Units)
Table 44. Global Cardiopulmonary Autotransfusion System Sales Quantity by Region (2026-2031) & (K Units)
Table 45. Global Cardiopulmonary Autotransfusion System Consumption Value by Region (2020-2025) & (USD Million)
Table 46. Global Cardiopulmonary Autotransfusion System Consumption Value by Region (2026-2031) & (USD Million)
Table 47. Global Cardiopulmonary Autotransfusion System Average Price by Region (2020-2025) & (USD/Unit)
Table 48. Global Cardiopulmonary Autotransfusion System Average Price by Region (2026-2031) & (USD/Unit)
Table 49. Global Cardiopulmonary Autotransfusion System Sales Quantity byType (2020-2025) & (K Units)
Table 50. Global Cardiopulmonary Autotransfusion System Sales Quantity byType (2026-2031) & (K Units)
Table 51. Global Cardiopulmonary Autotransfusion System Consumption Value byType (2020-2025) & (USD Million)
Table 52. Global Cardiopulmonary Autotransfusion System Consumption Value byType (2026-2031) & (USD Million)
Table 53. Global Cardiopulmonary Autotransfusion System Average Price byType (2020-2025) & (USD/Unit)
Table 54. Global Cardiopulmonary Autotransfusion System Average Price byType (2026-2031) & (USD/Unit)
Table 55. Global Cardiopulmonary Autotransfusion System Sales Quantity by Application (2020-2025) & (K Units)
Table 56. Global Cardiopulmonary Autotransfusion System Sales Quantity by Application (2026-2031) & (K Units)
Table 57. Global Cardiopulmonary Autotransfusion System Consumption Value by Application (2020-2025) & (USD Million)
Table 58. Global Cardiopulmonary Autotransfusion System Consumption Value by Application (2026-2031) & (USD Million)
Table 59. Global Cardiopulmonary Autotransfusion System Average Price by Application (2020-2025) & (USD/Unit)
Table 60. Global Cardiopulmonary Autotransfusion System Average Price by Application (2026-2031) & (USD/Unit)
Table 61. North America Cardiopulmonary Autotransfusion System Sales Quantity byType (2020-2025) & (K Units)
Table 62. North America Cardiopulmonary Autotransfusion System Sales Quantity byType (2026-2031) & (K Units)
Table 63. North America Cardiopulmonary Autotransfusion System Sales Quantity by Application (2020-2025) & (K Units)
Table 64. North America Cardiopulmonary Autotransfusion System Sales Quantity by Application (2026-2031) & (K Units)
Table 65. North America Cardiopulmonary Autotransfusion System Sales Quantity by Country (2020-2025) & (K Units)
Table 66. North America Cardiopulmonary Autotransfusion System Sales Quantity by Country (2026-2031) & (K Units)
Table 67. North America Cardiopulmonary Autotransfusion System Consumption Value by Country (2020-2025) & (USD Million)
Table 68. North America Cardiopulmonary Autotransfusion System Consumption Value by Country (2026-2031) & (USD Million)
Table 69. Europe Cardiopulmonary Autotransfusion System Sales Quantity byType (2020-2025) & (K Units)
Table 70. Europe Cardiopulmonary Autotransfusion System Sales Quantity byType (2026-2031) & (K Units)
Table 71. Europe Cardiopulmonary Autotransfusion System Sales Quantity by Application (2020-2025) & (K Units)
Table 72. Europe Cardiopulmonary Autotransfusion System Sales Quantity by Application (2026-2031) & (K Units)
Table 73. Europe Cardiopulmonary Autotransfusion System Sales Quantity by Country (2020-2025) & (K Units)
Table 74. Europe Cardiopulmonary Autotransfusion System Sales Quantity by Country (2026-2031) & (K Units)
Table 75. Europe Cardiopulmonary Autotransfusion System Consumption Value by Country (2020-2025) & (USD Million)
Table 76. Europe Cardiopulmonary Autotransfusion System Consumption Value by Country (2026-2031) & (USD Million)
Table 77. Asia-Pacific Cardiopulmonary Autotransfusion System Sales Quantity byType (2020-2025) & (K Units)
Table 78. Asia-Pacific Cardiopulmonary Autotransfusion System Sales Quantity byType (2026-2031) & (K Units)
Table 79. Asia-Pacific Cardiopulmonary Autotransfusion System Sales Quantity by Application (2020-2025) & (K Units)
Table 80. Asia-Pacific Cardiopulmonary Autotransfusion System Sales Quantity by Application (2026-2031) & (K Units)
Table 81. Asia-Pacific Cardiopulmonary Autotransfusion System Sales Quantity by Region (2020-2025) & (K Units)
Table 82. Asia-Pacific Cardiopulmonary Autotransfusion System Sales Quantity by Region (2026-2031) & (K Units)
Table 83. Asia-Pacific Cardiopulmonary Autotransfusion System Consumption Value by Region (2020-2025) & (USD Million)
Table 84. Asia-Pacific Cardiopulmonary Autotransfusion System Consumption Value by Region (2026-2031) & (USD Million)
Table 85. South America Cardiopulmonary Autotransfusion System Sales Quantity byType (2020-2025) & (K Units)
Table 86. South America Cardiopulmonary Autotransfusion System Sales Quantity byType (2026-2031) & (K Units)
Table 87. South America Cardiopulmonary Autotransfusion System Sales Quantity by Application (2020-2025) & (K Units)
Table 88. South America Cardiopulmonary Autotransfusion System Sales Quantity by Application (2026-2031) & (K Units)
Table 89. South America Cardiopulmonary Autotransfusion System Sales Quantity by Country (2020-2025) & (K Units)
Table 90. South America Cardiopulmonary Autotransfusion System Sales Quantity by Country (2026-2031) & (K Units)
Table 91. South America Cardiopulmonary Autotransfusion System Consumption Value by Country (2020-2025) & (USD Million)
Table 92. South America Cardiopulmonary Autotransfusion System Consumption Value by Country (2026-2031) & (USD Million)
Table 93. Middle East & Africa Cardiopulmonary Autotransfusion System Sales Quantity byType (2020-2025) & (K Units)
Table 94. Middle East & Africa Cardiopulmonary Autotransfusion System Sales Quantity byType (2026-2031) & (K Units)
Table 95. Middle East & Africa Cardiopulmonary Autotransfusion System Sales Quantity by Application (2020-2025) & (K Units)
Table 96. Middle East & Africa Cardiopulmonary Autotransfusion System Sales Quantity by Application (2026-2031) & (K Units)
Table 97. Middle East & Africa Cardiopulmonary Autotransfusion System Sales Quantity by Country (2020-2025) & (K Units)
Table 98. Middle East & Africa Cardiopulmonary Autotransfusion System Sales Quantity by Country (2026-2031) & (K Units)
Table 99. Middle East & Africa Cardiopulmonary Autotransfusion System Consumption Value by Country (2020-2025) & (USD Million)
Table 100. Middle East & Africa Cardiopulmonary Autotransfusion System Consumption Value by Country (2026-2031) & (USD Million)
Table 101. Cardiopulmonary Autotransfusion System Raw Material
Table 102. Key Manufacturers of Cardiopulmonary Autotransfusion System Raw Materials
Table 103. Cardiopulmonary Autotransfusion SystemTypical Distributors
Table 104. Cardiopulmonary Autotransfusion SystemTypical Customers
LIST OFFIGURES
Figure 1. Cardiopulmonary Autotransfusion System Picture
Figure 2. Global Cardiopulmonary Autotransfusion System Revenue byType, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Cardiopulmonary Autotransfusion System Revenue Market Share byType in 2024
Figure 4. Unwashed ATS Examples
Figure 5. Washed ATS Examples
Figure 6. Global Cardiopulmonary Autotransfusion System Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. Global Cardiopulmonary Autotransfusion System Revenue Market Share by Application in 2024
Figure 8. Heart Surgery Examples
Figure 9. Great OrganTransplant Surgery Examples
Figure 10. Other Surgery Examples
Figure 11. Global Cardiopulmonary Autotransfusion System Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 12. Global Cardiopulmonary Autotransfusion System Consumption Value andForecast (2020-2031) & (USD Million)
Figure 13. Global Cardiopulmonary Autotransfusion System Sales Quantity (2020-2031) & (K Units)
Figure 14. Global Cardiopulmonary Autotransfusion System Price (2020-2031) & (USD/Unit)
Figure 15. Global Cardiopulmonary Autotransfusion System Sales Quantity Market Share by Manufacturer in 2024
Figure 16. Global Cardiopulmonary Autotransfusion System Revenue Market Share by Manufacturer in 2024
Figure 17. Producer Shipments of Cardiopulmonary Autotransfusion System by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 18.Top 3 Cardiopulmonary Autotransfusion System Manufacturer (Revenue) Market Share in 2024
Figure 19.Top 6 Cardiopulmonary Autotransfusion System Manufacturer (Revenue) Market Share in 2024
Figure 20. Global Cardiopulmonary Autotransfusion System Sales Quantity Market Share by Region (2020-2031)
Figure 21. Global Cardiopulmonary Autotransfusion System Consumption Value Market Share by Region (2020-2031)
Figure 22. North America Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 23. Europe Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 24. Asia-Pacific Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 25. South America Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 26. Middle East & Africa Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 27. Global Cardiopulmonary Autotransfusion System Sales Quantity Market Share byType (2020-2031)
Figure 28. Global Cardiopulmonary Autotransfusion System Consumption Value Market Share byType (2020-2031)
Figure 29. Global Cardiopulmonary Autotransfusion System Average Price byType (2020-2031) & (USD/Unit)
Figure 30. Global Cardiopulmonary Autotransfusion System Sales Quantity Market Share by Application (2020-2031)
Figure 31. Global Cardiopulmonary Autotransfusion System Revenue Market Share by Application (2020-2031)
Figure 32. Global Cardiopulmonary Autotransfusion System Average Price by Application (2020-2031) & (USD/Unit)
Figure 33. North America Cardiopulmonary Autotransfusion System Sales Quantity Market Share byType (2020-2031)
Figure 34. North America Cardiopulmonary Autotransfusion System Sales Quantity Market Share by Application (2020-2031)
Figure 35. North America Cardiopulmonary Autotransfusion System Sales Quantity Market Share by Country (2020-2031)
Figure 36. North America Cardiopulmonary Autotransfusion System Consumption Value Market Share by Country (2020-2031)
Figure 37. United States Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 38. Canada Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 39. Mexico Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 40. Europe Cardiopulmonary Autotransfusion System Sales Quantity Market Share byType (2020-2031)
Figure 41. Europe Cardiopulmonary Autotransfusion System Sales Quantity Market Share by Application (2020-2031)
Figure 42. Europe Cardiopulmonary Autotransfusion System Sales Quantity Market Share by Country (2020-2031)
Figure 43. Europe Cardiopulmonary Autotransfusion System Consumption Value Market Share by Country (2020-2031)
Figure 44. Germany Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 45.France Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 46. United Kingdom Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 47. Russia Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 48. Italy Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 49. Asia-Pacific Cardiopulmonary Autotransfusion System Sales Quantity Market Share byType (2020-2031)
Figure 50. Asia-Pacific Cardiopulmonary Autotransfusion System Sales Quantity Market Share by Application (2020-2031)
Figure 51. Asia-Pacific Cardiopulmonary Autotransfusion System Sales Quantity Market Share by Region (2020-2031)
Figure 52. Asia-Pacific Cardiopulmonary Autotransfusion System Consumption Value Market Share by Region (2020-2031)
Figure 53. China Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 54. Japan Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 55. South Korea Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 56. India Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 57. Southeast Asia Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 58. Australia Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 59. South America Cardiopulmonary Autotransfusion System Sales Quantity Market Share byType (2020-2031)
Figure 60. South America Cardiopulmonary Autotransfusion System Sales Quantity Market Share by Application (2020-2031)
Figure 61. South America Cardiopulmonary Autotransfusion System Sales Quantity Market Share by Country (2020-2031)
Figure 62. South America Cardiopulmonary Autotransfusion System Consumption Value Market Share by Country (2020-2031)
Figure 63. Brazil Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 64. Argentina Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 65. Middle East & Africa Cardiopulmonary Autotransfusion System Sales Quantity Market Share byType (2020-2031)
Figure 66. Middle East & Africa Cardiopulmonary Autotransfusion System Sales Quantity Market Share by Application (2020-2031)
Figure 67. Middle East & Africa Cardiopulmonary Autotransfusion System Sales Quantity Market Share by Country (2020-2031)
Figure 68. Middle East & Africa Cardiopulmonary Autotransfusion System Consumption Value Market Share by Country (2020-2031)
Figure 69.Turkey Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 70. Egypt Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 71. Saudi Arabia Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 72. South Africa Cardiopulmonary Autotransfusion System Consumption Value (2020-2031) & (USD Million)
Figure 73. Cardiopulmonary Autotransfusion System Market Drivers
Figure 74. Cardiopulmonary Autotransfusion System Market Restraints
Figure 75. Cardiopulmonary Autotransfusion System MarketTrends
Figure 76. PortersFiveForces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Cardiopulmonary Autotransfusion System in 2024
Figure 78. Manufacturing Process Analysis of Cardiopulmonary Autotransfusion System
Figure 79. Cardiopulmonary Autotransfusion System Industrial Chain
Figure 80. Sales Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
